BenevolentAI and Rancho BioSciences discuss how large-scale single-cell transcriptomics data is revolutionizing drug discovery by providing deeper insights into cellular mechanisms.

We discuss:

• The importance of high-quality data to produce meaningful insights and the robust workflows created to deliver analysis-ready single-cell transcriptomics datasets at scale

• Introduction to BenevolentAI’s target discovery platform as illustrated by several cases studies that demonstrate its utility for mechanistic drug discovery.

• How to prepare volumes of high-quality data for meaningful insights